118 related articles for article (PubMed ID: 38087399)
1. Integrated metabolomics and network pharmacology to reveal the lipid-lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats.
Zhao L; Wang S; Xu X; Guo W; Yang J; Liu Y; Xie S; Piao G; Xu T; Wang Y; Xu Y
J Sci Food Agric; 2024 Apr; 104(6):3265-3274. PubMed ID: 38087399
[TBL] [Abstract][Full Text] [Related]
2. Serum metabonomics coupled with HPLC-LTQ/orbitrap MS and multivariate data analysis on the ameliorative effects of Bidens bipinnata L. in hyperlipidemic rats.
Wang YQ; Li SJ; Man YH; Zhuang G
J Ethnopharmacol; 2020 Nov; 262():113196. PubMed ID: 32730873
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of Didang Decoction in prevention of anti-atherosclerosis and hyperlipidemia by HPLC-Q-TOF-MS/MS and network pharmacology based on theory of "nutrients return to heart and fat accumulates in channels"].
Wu XZ; Kang J; Li Y; Pan JX
Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(5):1352-1369. PubMed ID: 37005819
[TBL] [Abstract][Full Text] [Related]
4. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia.
Zeng B; Qi L; Wu S; Liu N; Wang J; Nie K; Xia L; Yu S
J Vis Exp; 2023 Apr; (194):. PubMed ID: 37092814
[TBL] [Abstract][Full Text] [Related]
6. [Difference of lipid-lowering efficacy of "Xinjianqu" before and after fermentation and its mechanism based on LKB1-AMPK pathway and 16S rDNA sequencing technology].
Li DH; Wang RS; Zhang ZL; Zhu JG; Sun MM; Qiao J
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2146-2159. PubMed ID: 37282903
[TBL] [Abstract][Full Text] [Related]
7. Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia.
Chen Y; Li K; Zhao H; Hao Z; Yang Y; Gao M; Zhao D
J Transl Med; 2022 Sep; 20(1):412. PubMed ID: 36076294
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
[TBL] [Abstract][Full Text] [Related]
9. Lei-gong-gen formula granule attenuates hyperlipidemia in rats via cGMP-PKG signaling pathway.
Lan T; Li Q; Chang M; Yin C; Zhu D; Wu Z; Li X; Zhang W; Yue B; Shi J; Yuan H; Su Z; Guo H
J Ethnopharmacol; 2020 Oct; 260():112989. PubMed ID: 32526339
[TBL] [Abstract][Full Text] [Related]
10. Holothuria Leucospilota polysaccharides alleviate hyperlipidemia via alteration of lipid metabolism and inflammation-related gene expression.
Lu S; Yuan Y; Chen F; Zheng Y; Li C; Cao J; Xia G; Liu Z; Shen X; He Y; Zhou D; Zhu K
J Food Biochem; 2022 Dec; 46(12):e14392. PubMed ID: 36111651
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology combined with metabolomics and lipidomics to reveal the hypolipidemic mechanism of
Yan P; Wei Y; Wang M; Tao J; Ouyang H; Du Z; Li S; Jiang H
Food Funct; 2022 Apr; 13(8):4714-4733. PubMed ID: 35383784
[No Abstract] [Full Text] [Related]
12. Fecal metabolomics analysis for deciphering the lipid-lowering effect of Qizhi capsule on high-fat feed induced hyperlipidemia.
Ren J; Fang H; Yang L; Sun H; Song H; Yan G; Han Y; Wang X
J Ethnopharmacol; 2023 May; 308():116270. PubMed ID: 36806341
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the components compatibility of Scutellariae Radix and Coptidis Rhizoma on mice with hyperlipidemia by regulating the Cyp4a family.
Gao Y; Sun YY; Bai D; Wu XX
J Ethnopharmacol; 2024 Sep; 331():118263. PubMed ID: 38677575
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the mechanisms underlying the anti-hyperlipidemic effects of Laportea bulbifera using integrated serum metabolomics and network pharmacology.
Shi Q; Lin Y; Huang L; Jin S; Huang R; Zhang L; Song C; Xu L; Zhang S
Biomed Chromatogr; 2023 Oct; 37(10):e5707. PubMed ID: 37496197
[TBL] [Abstract][Full Text] [Related]
15. [Lipid-lowering effect and mechanism of Danhong Injection on hyperlipidemia rats based on lipid metabolism disorder].
DU HX; Zhou HF; He Y; Wan HT; Yang JH
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3203-3210. PubMed ID: 32726030
[TBL] [Abstract][Full Text] [Related]
16. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
Ji H; Liu Y; He F; An R; Du Z
J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
[TBL] [Abstract][Full Text] [Related]
17. Integration of non-targeted metabolomics with network pharmacology deciphers the anxiolytic mechanisms of Platycladi Semen extracts in CUMS mice.
Xie J; Li Y; Liang Y; Kui H; Wang C; Huang J
J Ethnopharmacol; 2023 Oct; 315():116571. PubMed ID: 37201666
[TBL] [Abstract][Full Text] [Related]
18. A Network Pharmacology Approach to Explore the Mechanisms of Qishen Granules in Heart Failure.
Liu J; Li Y; Zhang Y; Huo M; Sun X; Xu Z; Tan N; Du K; Wang Y; Zhang J; Wang W
Med Sci Monit; 2019 Oct; 25():7735-7745. PubMed ID: 31613871
[TBL] [Abstract][Full Text] [Related]
19. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the mechanism of action of quercetin in the treatment of hyperlipidemia based on metabolomics and intestinal flora.
Wang T; Liu L; Deng J; Jiang Y; Yan X; Liu W
Food Funct; 2023 Feb; 14(4):2112-2127. PubMed ID: 36740912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
